Keyphrases
Clinical Outcomes
100%
Bloodstream Infection
100%
Antimicrobial Therapy
100%
Carbapenem-resistant Acinetobacter Baumannii
100%
Acinetobacter Baumannii (A. baumannii)
100%
Carbapenems
100%
Carbapenem Resistance
100%
Baumannii
100%
Survivors
40%
Hospital Mortality
40%
Post-infection
40%
Negative Culture
40%
Improved Outcomes
20%
Patient Outcomes
20%
Comorbidity
20%
Bacteremia
20%
Strong Predictor
20%
Bivariate Analysis
20%
Retrospective Cohort Study
20%
Length of Stay
20%
Number of Days
20%
Logistic Regression
20%
Cox Proportional Hazards Model
20%
Mortality Prediction
20%
Lactams
20%
Active Agent
20%
Multivariate Model
20%
Group 14
20%
Polymyxin
20%
Chronically Ill
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antimicrobial Therapy
100%
Carbapenem
100%
Bloodstream Infection
100%
Carbapenem Resistance
100%
Acinetobacter Baumannii
100%
Hospital Mortality
20%
Cohort Study
10%
Prevalence
10%
Beta Lactam
10%
Polymyxin
10%
Comorbidity
10%
Nursing and Health Professions
Clinical Outcome
100%
Antimicrobial Therapy
100%
Bloodstream Infection
100%
Carbapenem
100%
Hospital Mortality
16%
Length of Stay
8%
Treatment Outcome
8%
Prevalence
8%
Cohort Analysis
8%
Logistic Regression Analysis
8%
Proportional Hazards Model
8%
Bivariate Analysis
8%
Beta Lactam
8%
Polymyxin
8%
Comorbidity
8%
Medicine and Dentistry
Antimicrobial Therapy
100%
Bloodstream Infection
100%
Acinetobacter Baumannii
100%
Carbapenem
100%
Hospital Mortality
16%
Prevalence
8%
Logistic Regression Analysis
8%
Retrospective Cohort Study
8%
Bivariate Analysis
8%
Proportional Hazards Model
8%
Beta Lactam
8%
Polymyxin
8%
Comorbidity
8%
Immunology and Microbiology
Hospital Mortality
100%
Acinetobacter Baumannii
100%
Prevalence
50%
Polymyxin
50%
Comorbidity
50%